Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Oncotarget. 2018 Nov 27;9(93):36645. doi: 10.18632/oncotarget.26415.

Kimberley Hanson¹, Stephen D Robinson¹, Karamallah Al-Yousuf^{2

3}, Adam E Hendry¹, Darren W Sexton^{4

5}, Victoria Sherwood^{2

3}, Grant N Wheeler¹

¹ School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
² School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
³ Present address: Division of Cancer Sciences, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK.
⁴ Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
⁵ Present address: Pharmacy and Biomedical Sciences, Liverpool John Moores University, Liverpool, L3 3AF, UK.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.23378.].